8-K Announcements
6Material company update
Mar 24, 2026·SEC
Material company update
Mar 4, 2026·SEC
Material company update
Jan 26, 2026·SEC
Cardlytics, Inc.(CDLX)Earnings, Financials & Key Ratios
CDLX•NASDAQ
$0.80
$44M mkt cap·Price updated May 6, 2026
SectorCommunication ServicesIndustryAdvertising & MarketingSub-IndustryPerformance and commerce marketing
AboutCardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.Show more
- Revenue$233M-16.2%
- EBITDA-$20M+88.2%
- Net Income-$103M+45.3%
- EPS (Diluted)-1.95+50.1%
- Gross Margin45.05%+3.7%
- EBITDA Margin-8.46%+86.0%
- Operating Margin-20.21%+71.2%
- Net Margin-44.36%+34.8%
- ROE-326.02%-76.3%
- ROIC-18.31%+66.6%
- Interest Coverage-4.43+78.1%
CDLX Key Insights
Cardlytics, Inc. (CDLX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Profits declining 13.3% over 5 years
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
CDLX Price & Volume
Cardlytics, Inc. (CDLX) stock price & volume — 10-year historical chart
Loading chart...
CDLX Growth Metrics
Cardlytics, Inc. (CDLX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years11.63%
5 Years4.53%
3 Years-7.89%
TTM-16.18%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM45.33%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM49.18%
Return on Capital
10 Years-49.91%
5 Years-39.81%
3 Years-37.82%
Last Year-20.9%
CDLX Peer Comparison
Cardlytics, Inc. (CDLX) competitors in Performance and commerce marketing — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 PERI | 477.39M | 10.65 | -56.05 | -11.71% | -1.8% | -1.17% | 0.06 | |
 MGNI | 1.92B | 13.39 | 14.09 | 6.85% | 21.96% | 18.57% | 0.30 | |
 APPS | 476.06M | 3.98 | -4.47 | -9.91% | -7.88% | -21.55% | 2.72 | |
 ACMR | 3.67B | 55.38 | 40.42 | 15.24% | 10.44% | 6.11% | 0.16 | |
 IAS | 1.74B | 10.34 | 44.96 | 11.75% | 7.91% | 4.23% | 0.06 | |
 TTD | 11.42B | 23.99 | 26.36 | 18.47% | 15.31% | 16.89% | 0.18 | |
 CRTO | 811.27M | 15.86 | 5.98 | 0.6% | 6.01% | 9.9% | 0.13 | |
 PUBM | 476.66M | 10.14 | -32.71 | -2.86% | -5.11% | -5.51% | 0.17 |
Compare CDLX vs Peers
Cardlytics, Inc. (CDLX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CDLX Income Statement
Cardlytics, Inc. (CDLX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 130.37M | 150.68M | 210.43M | 186.89M | 267.12M | 298.54M | 309.2M | 278.3M | 233.27M |
| Revenue Growth % | 15.55% | 15.59% | 39.65% | -11.19% | 42.93% | 11.76% | 3.57% | -10% | -16.18% |
| Cost of Goods Sold | 80.26M | 96M | 130.97M | 123.62M | 163.78M | 185.91M | 178.83M | 157.4M | 128.19M |
| COGS % of Revenue | 61.56% | 63.71% | 62.24% | 66.14% | 61.31% | 62.27% | 57.83% | 56.56% | 54.95% |
| Gross Profit | 50.11M▲ 0% | 54.68M▲ 9.1% | 79.46M▲ 45.3% | 63.27M▼ 20.4% | 103.34M▲ 63.3% | 112.63M▲ 9.0% | 130.38M▲ 15.8% | 120.89M▼ 7.3% | 105.08M▼ 13.1% |
| Gross Margin % | 38.44% | 36.29% | 37.76% | 33.86% | 38.69% | 37.73% | 42.17% | 43.44% | 45.05% |
| Gross Profit Growth % | 24% | 9.13% | 45.31% | -20.37% | 63.32% | 8.99% | 15.76% | -7.27% | -13.08% |
| Operating Expenses | 67.2M | 95.6M | 96.78M | 117.2M | 225.94M | 570.41M | 266.05M | 316.39M | 152.22M |
| OpEx % of Revenue | 51.55% | 63.44% | 45.99% | 62.71% | 84.58% | 191.07% | 86.04% | 113.69% | 65.25% |
| Selling, General & Admin | 52.03M | 76.11M | 80.55M | 91.84M | 132.22M | 156.19M | 116.24M | 109.13M | 86.75M |
| SG&A % of Revenue | 39.91% | 50.51% | 38.28% | 49.14% | 49.5% | 52.32% | 37.59% | 39.21% | 37.19% |
| Research & Development | 12.15M | 16.21M | 11.7M | 17.53M | 38.1M | 54.44M | 51.35M | 49.61M | 39.77M |
| R&D % of Revenue | 9.32% | 10.76% | 5.56% | 9.38% | 14.27% | 18.23% | 16.61% | 17.83% | 17.05% |
| Other Operating Expenses | 6.28M | -2.1M | 4.54M | 7.83M | 55.62M | 359.78M | 98.46M | 157.66M | 25.71M |
| Operating Income | -17.1M▲ 0% | -40.92M▼ 139.3% | -17.32M▲ 57.7% | -53.92M▼ 211.2% | -122.6M▼ 127.4% | -457.78M▼ 273.4% | -135.67M▲ 70.4% | -195.5M▼ 44.1% | -47.14M▲ 75.9% |
| Operating Margin % | -13.12% | -27.15% | -8.23% | -28.85% | -45.9% | -153.34% | -43.88% | -70.25% | -20.21% |
| Operating Income Growth % | 69.59% | -139.29% | 57.66% | -211.24% | -127.36% | -273.39% | 70.36% | -44.1% | 75.89% |
| EBITDA | -14.07M | -37.63M | -12.79M | -42.33M | -86.94M | -414.04M | -106.16M | -167.62M | -19.73M |
| EBITDA Margin % | -10.79% | -24.98% | -6.08% | -22.65% | -32.55% | -138.69% | -34.33% | -60.23% | -8.46% |
| EBITDA Growth % | 72.95% | -167.47% | 66.02% | -230.97% | -105.39% | -376.21% | 74.36% | -57.9% | 88.23% |
| D&A (Non-Cash Add-back) | 3.03M | 3.28M | 4.54M | 11.59M | 35.65M | 43.74M | 29.52M | 27.88M | 27.41M |
| EBIT | -11.31M | -49.78M | -16.6M | -52.37M | -123.87M | -464.15M | -128.52M | -180.4M | -47.14M |
| Net Interest Income | -8.24M | -3.26M | -548K | -3.05M | -12.56M | -2.56M | -2.34M | -5.55M | -7.92M |
| Interest Income | 0 | 0 | 829K | 440K | 297K | 1.44M | 3.85M | 3.35M | 2.71M |
| Interest Expense | 8.24M | 3.26M | 1.38M | 3.49M | 12.86M | 3.99M | 6.18M | 8.9M | 10.63M |
| Other Income/Expense | -2.54M | -12.13M | 181K | -1.5M | -13.83M | -8.93M | 968K | 6.2M | -56.35M |
| Pretax Income | -19.64M▲ 0% | -53.04M▼ 170.1% | -17.14M▲ 67.7% | -55.42M▼ 223.3% | -136.43M▼ 146.2% | -466.71M▼ 242.1% | -134.7M▲ 71.1% | -189.3M▼ 40.5% | -103.49M▲ 45.3% |
| Pretax Margin % | -15.07% | -35.2% | -8.15% | -29.65% | -51.07% | -156.33% | -43.56% | -68.02% | -44.36% |
| Income Tax | 0 | 0 | 0 | 0 | -7.86M | -1.45M | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 5.76% | 0.31% | 0% | 0% | 0% |
| Net Income | -19.64M▲ 0% | -53.04M▼ 170.1% | -17.14M▲ 67.7% | -55.42M▼ 223.3% | -128.56M▼ 132.0% | -465.26M▼ 261.9% | -134.7M▲ 71.0% | -189.3M▼ 40.5% | -103.49M▲ 45.3% |
| Net Margin % | -15.07% | -35.2% | -8.15% | -29.65% | -48.13% | -155.85% | -43.56% | -68.02% | -44.36% |
| Net Income Growth % | 74.05% | -170.06% | 67.68% | -223.27% | -131.97% | -261.89% | 71.05% | -40.54% | 45.33% |
| Net Income (Continuing) | -19.64M | -53.04M | -17.14M | -55.42M | -128.56M | -465.26M | -134.7M | -189.3M | -103.49M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.01▲ 0% | -2.78▼ 175.2% | -0.75▲ 73.0% | -2.15▼ 186.7% | -3.99▼ 85.6% | -13.92▼ 248.9% | -3.69▲ 73.5% | -3.91▼ 6.0% | -1.95▲ 50.1% |
| EPS Growth % | 81.3% | -175.25% | 73.02% | -186.67% | -85.58% | -248.87% | 73.49% | -5.96% | 50.13% |
| EPS (Basic) | -1.01 | -2.78 | -0.75 | -2.15 | -3.99 | -13.92 | -3.69 | -3.91 | -1.95 |
| Diluted Shares Outstanding | 19.52M | 19.06M | 23.75M | 27.21M | 32.2M | 33.42M | 36.49M | 48.36M | 53.11M |
| Basic Shares Outstanding | 19.52M | 19.06M | 23.75M | 27.21M | 32.2M | 33.42M | 36.49M | 48.36M | 53.11M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
CDLX Balance Sheet
Cardlytics, Inc. (CDLX) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 74.63M | 124.37M | 195.73M | 385.59M | 358.73M | 250.04M | 223.93M | 177.98M | 137.28M |
| Cash & Short-Term Investments | 21.26M | 39.62M | 104.46M | 293.24M | 233.47M | 121.91M | 91.83M | 65.59M | 48.72M |
| Cash Only | 21.26M | 39.62M | 104.46M | 293.24M | 233.47M | 121.91M | 91.83M | 65.59M | 48.72M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 51.25M | 60.54M | 85.36M | 86.56M | 117.18M | 120.08M | 126M | 107.05M | 85.26M |
| Days Sales Outstanding | 143.48 | 146.65 | 148.06 | 169.04 | 160.12 | 146.81 | 148.74 | 140.4 | 133.4 |
| Inventory | 0 | 20.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | 76.98 | - | - | - | - | - | - | - |
| Other Current Assets | 2.12M | 20.25M | 129K | 110K | 95K | 8.06M | 6.1M | 5.34M | 3.3M |
| Total Non-Current Assets | 26.13M | 29.39M | 28.58M | 36.95M | 905.07M | 441.19M | 350.22M | 214.73M | 148.36M |
| Property, Plant & Equipment | 7.32M | 10.23M | 14.29M | 24.63M | 21.47M | 12.49M | 10.63M | 8.94M | 6.97M |
| Fixed Asset Turnover | 17.81x | 14.73x | 14.73x | 7.59x | 12.44x | 23.91x | 29.08x | 31.14x | 33.46x |
| Goodwill | 0 | 0 | 0 | 0 | 742.52M | 352.72M | 277.2M | 159.43M | 110.31M |
| Intangible Assets | 961K | 2M | 4.2M | 6.75M | 138.68M | 73.4M | 59.65M | 11.37M | 5.55M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 17.85M | 17.17M | 10.09M | 5.57M | 2.41M | 2.59M | 2.73M | 34.99M | 25.53M |
| Total Assets | 100.76M▲ 0% | 153.76M▲ 52.6% | 224.31M▲ 45.9% | 422.54M▲ 88.4% | 1.26B▲ 199.1% | 691.24M▼ 45.3% | 574.14M▼ 16.9% | 392.71M▼ 31.6% | 285.64M▼ 27.3% |
| Asset Turnover | 1.29x | 0.98x | 0.94x | 0.44x | 0.21x | 0.43x | 0.54x | 0.71x | 0.82x |
| Asset Growth % | 16% | 52.61% | 45.88% | 88.37% | 199.1% | -45.3% | -16.94% | -31.6% | -27.26% |
| Total Current Liabilities | 42.14M | 51.92M | 78.4M | 81.27M | 327.35M | 248.94M | 171.15M | 148.96M | 78.39M |
| Accounts Payable | 1.55M | 2.1M | 1.23M | 1.36M | 4.62M | 3.77M | 4.42M | 3.69M | 3.36M |
| Days Payables Outstanding | 7.07 | 7.98 | 3.42 | 4.02 | 10.29 | 7.39 | 9.03 | 8.55 | 9.57 |
| Short-Term Debt | 44K | 21K | 0 | 0 | 0 | 0 | 10K | 45.86M | 1.61M |
| Deferred Revenue (Current) | 132K | 346K | 1.13M | 349K | 3.28M | 1.75M | 2.4M | 2.15M | 2.59M |
| Other Current Liabilities | 4.59M | 43.52M | 8.19M | 7.58M | 194.61M | 114.61M | 150.52M | 37.04M | 70.83M |
| Current Ratio | 1.77x | 2.40x | 2.50x | 4.74x | 1.10x | 1.00x | 1.31x | 1.19x | 1.75x |
| Quick Ratio | 1.77x | 2.01x | 2.50x | 4.74x | 1.10x | 1.00x | 1.31x | 1.19x | 1.75x |
| Cash Conversion Cycle | - | 215.65 | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 267.31M | 49.87M | 2.65M | 184.07M | 245.75M | 230.69M | 268.2M | 173.76M | 213.76M |
| Long-Term Debt | 56.91M | 46.69M | 0 | 174.01M | 184.4M | 226.05M | 257.58M | 167.73M | 208.92M |
| Capital Lease Obligations | 57K | 37K | 13K | 9.38M | 6.8M | 4.31M | 6.39M | 6.03M | 4.79M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 210.34M | 3.14M | 2.63M | 679K | 54.38M | 0 | 4.16M | 0 | 0 |
| Total Liabilities | 309.44M | 101.79M | 81.05M | 265.35M | 573.1M | 479.63M | 439.35M | 322.72M | 292.15M |
| Total Debt | 57.01M | 46.71M | 37K | 188.11M | 197.23M | 235.26M | 266.11M | 221.65M | 215.31M |
| Net Debt | 35.75M | 7.09M | -104.42M | -105.13M | -36.24M | 113.36M | 174.28M | 156.06M | 166.59M |
| Debt / Equity | - | 0.90x | 0.00x | 1.20x | 0.29x | 1.11x | 1.97x | 3.17x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -1.37x | -15.25x | -12.05x | -15.02x | -9.63x | -116.21x | -20.79x | -20.26x | -4.43x |
| Total Equity | -208.69M▲ 0% | 51.98M▲ 124.9% | 143.27M▲ 175.6% | 157.19M▲ 9.7% | 690.7M▲ 339.4% | 211.6M▼ 69.4% | 134.8M▼ 36.3% | 69.99M▼ 48.1% | -6.51M▼ 109.3% |
| Equity Growth % | 3.76% | 124.91% | 175.65% | 9.72% | 339.4% | -69.36% | -36.3% | -48.08% | -109.3% |
| Book Value per Share | -10.69 | 2.73 | 6.03 | 5.78 | 21.45 | 6.33 | 3.69 | 1.45 | -0.12 |
| Total Shareholders' Equity | -208.69M | 51.98M | 143.27M | 157.19M | 690.7M | 211.6M | 134.8M | 69.99M | -6.51M |
| Common Stock | 0 | 7K | 8K | 8K | 9K | 9K | 9K | 10K | 10K |
| Retained Earnings | -268.44M | -321.49M | -338.63M | -394.05M | -522.62M | -976.57M | -1.11B | -1.3B | -1.4B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.07M | 1.99M | 1.31M | -192K | 486K | 5.6M | 2.47M | 3.6M | -2M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CDLX Cash Flow Statement
Cardlytics, Inc. (CDLX) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -22.1M | -19M | 11.46M | -7.6M | -38.52M | -53.9M | -185K | -8.82M | 9.29M |
| Operating CF Margin % | -16.95% | -12.61% | 5.44% | -4.07% | -14.42% | -18.06% | -0.06% | -3.17% | 3.98% |
| Operating CF Growth % | 31.99% | 14.06% | 160.32% | -166.32% | -407.01% | -39.93% | 99.66% | -4669.73% | 205.28% |
| Net Income | -19.64M | -53.04M | -17.14M | -55.42M | -128.56M | -465.26M | -134.7M | -189.3M | -103.49M |
| Depreciation & Amortization | 3.03M | 3.28M | 4.54M | 11.59M | 35.65M | 43.74M | 29.52M | 27.88M | 27.41M |
| Stock-Based Compensation | 5.15M | 26.79M | 15.85M | 32.4M | 50.26M | 44.69M | 40.98M | 40.37M | 28.13M |
| Deferred Taxes | 654K | 6.76M | 0 | 0 | -7.86M | -1.45M | 0 | 0 | 0 |
| Other Non-Cash Items | 2.93M | 644K | 3.6M | 7.59M | 18.68M | 335.7M | 77.5M | 128.01M | 51.53M |
| Working Capital Changes | -14.22M | -3.43M | 4.62M | -3.75M | -6.7M | -11.32M | -13.47M | -15.77M | 5.71M |
| Change in Receivables | -7.5M | -9.43M | -26.02M | -2.4M | -27.94M | -4.55M | -7.72M | 12.5M | 20.64M |
| Change in Inventory | 1.99M | 8.96M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.91M | 911K | -601K | 16K | 1.26M | -893K | 239K | 499K | 179K |
| Cash from Investing | -1.65M | -7.34M | -11.02M | -10.12M | -506.69M | -15.76M | -10.06M | -18.75M | -15.3M |
| Capital Expenditures | -1.65M | -7.34M | -8.28M | -5.41M | -3.11M | -1.17M | -667K | -1.56M | 0 |
| CapEx % of Revenue | 1.26% | 4.87% | 3.93% | 2.89% | 1.16% | 0.39% | 0.22% | 0.56% | 0.21% |
| Acquisitions | 0 | 0 | 0 | 0 | -494.13M | -2.27M | 2.33M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -432K | -1.42M | -2.74M | -4.71M | -9.46M | -12.31M | -11.72M | -17.18M | -15.3M |
| Cash from Financing | 21.76M | 65.19M | 44.18M | 206.43M | 486M | -39.99M | -20.03M | 1.44M | -11.12M |
| Debt Issued (Net) | 12.4M | -5.15M | -46.7M | 223.08M | 0 | -35K | 29.97M | -26.8M | -6.12M |
| Equity Issued (Net) | 0 | 72.33M | 91.22M | 10.19M | 486.39M | -39.62M | 55K | 48.65M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -40M | 0 | 0 | 0 |
| Other Financing | 9.36M | -2M | -339K | -26.83M | -390K | -331K | -50.05M | -20.4M | -5M |
| Net Change in Cash | -1.71M▲ 0% | 38.61M▲ 2363.1% | 44.72M▲ 15.8% | 188.76M▲ 322.1% | -59.79M▼ 131.7% | -111.58M▼ 86.6% | -30.16M▲ 73.0% | -26.24M▲ 13.0% | -16.88M▲ 35.7% |
| Free Cash Flow | -23.75M▲ 0% | -26.34M▼ 10.9% | 437K▲ 101.7% | -17.71M▼ 4153.8% | -51.09M▼ 188.4% | -67.39M▼ 31.9% | -12.58M▲ 81.3% | -28.12M▼ 123.6% | 8.81M▲ 131.3% |
| FCF Margin % | -18.22% | -17.48% | 0.21% | -9.48% | -19.13% | -22.57% | -4.07% | -10.11% | 3.78% |
| FCF Growth % | 32.23% | -10.9% | 101.66% | -4153.78% | -188.38% | -31.91% | 81.34% | -123.6% | 131.33% |
| FCF per Share | -1.22 | -1.38 | 0.02 | -0.65 | -1.59 | -2.02 | -0.34 | -0.58 | 0.17 |
| FCF Conversion (FCF/Net Income) | 1.13x | 0.36x | -0.67x | 0.14x | 0.30x | 0.12x | 0.00x | 0.05x | -0.09x |
| Interest Paid | 0 | 0 | 1.27M | 63K | 2.33M | 2.38M | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CDLX Key Ratios
Cardlytics, Inc. (CDLX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -102.05% | -17.56% | -36.89% | -30.33% | -103.13% | -77.77% | -184.88% | -326.02% |
| Return on Invested Capital (ROIC) | - | - | - | -26.54% | -88.97% | -26.03% | -70.11% | -32.1% | -54.8% | -18.31% |
| Gross Margin | 35.82% | 38.44% | 36.29% | 37.76% | 33.86% | 38.69% | 37.73% | 42.17% | 43.44% | 45.05% |
| Net Margin | -67.09% | -15.07% | -35.2% | -8.15% | -29.65% | -48.13% | -155.85% | -43.56% | -68.02% | -44.36% |
| Debt / Equity | - | - | 0.90x | 0.00x | 1.20x | 0.29x | 1.11x | 1.97x | 3.17x | - |
| Interest Coverage | -4.92x | -1.37x | -15.25x | -12.05x | -15.02x | -9.63x | -116.21x | -20.79x | -20.26x | -4.43x |
| FCF Conversion | 0.43x | 1.13x | 0.36x | -0.67x | 0.14x | 0.30x | 0.12x | 0.00x | 0.05x | -0.09x |
| Revenue Growth | 45.32% | 15.55% | 15.59% | 39.65% | -11.19% | 42.93% | 11.76% | 3.57% | -10% | -16.18% |
CDLX SEC Filings & Documents
Cardlytics, Inc. (CDLX) SEC filings — annual & quarterly reports (10-K, 10-Q)
CDLX Frequently Asked Questions
Cardlytics, Inc. (CDLX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Cardlytics, Inc. (CDLX) reported $233.3M in revenue for fiscal year 2025. This represents a 200% increase from $77.6M in 2015.
Cardlytics, Inc. (CDLX) saw revenue decline by 16.2% over the past year.
Cardlytics, Inc. (CDLX) reported a net loss of $103.5M for fiscal year 2025.
Dividend & Returns
Cardlytics, Inc. (CDLX) has a return on equity (ROE) of -326.0%. Negative ROE indicates the company is unprofitable.
Cardlytics, Inc. (CDLX) generated $4.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More CDLX
Cardlytics, Inc. (CDLX) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates